Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by cortical blindness, intellectual deficit, and polydactyly.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cortical blindness-intellectual disability-polydactyly syndrome.
1 publication has been identified in PubMed for cortical blindness-intellectual disability-polydactyly syndrome. Research spans Review / Meta-Analysis (100%).
Zhang Q (2024). [PMID: 39126056](https://pubmed.ncbi.nlm.nih.gov/39126056/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 17, 2026, 10:23 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center